VivoSeq
Other

Hirsutism

3

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Hirsutism is an early-stage landscape with 3 programs across 0 companies. 2 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

0/100

Mech. Concentration

33/100

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical1

Finasteride

Organon and Co

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved2

Eflornithine

USWM, LLC (dba US WorldMeds)

Isotretinoin

Conrado Roberto Hoffmann Filho

Analysis

Trial Status

3

clinical trials

Completed3 · 100%

Clinical Trials

Trial Activity

Topical Finasteride in the Treatment of Idiopathic Hirsutism
Completed·IIran University of Medical Sciences·N/A·NCT00564252·56 enrolled
Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism
Completed·—·Phase 4·NCT01817894·22 enrolled
Effects of Isotretinoin on The Gonads and Hirsutism
Completed·KKayseri Education and Research Hospital·Phase 4·NCT02855138·80 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)